Alan L. Harvey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alan L. Harvey has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
A. Wallace Hayes
1 shared publicationAbby Collier
1 shared publicationAlan Kennedy
WestCHEM, Department of Pure & Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow, Scotland
1 shared publication- Albert P. Li
In Vitro ADMET Laboratories Inc., United States
1 shared publication - Alvaro M. Viljoen
Department of Pharmaceutical Sciences, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa
1 shared publication B. Robertson
Department of Physiology and Pharmacology, University of Strathclyde, Glasgow G4 0NR, UK
1 shared publication
Latest Publications
- 1 October 2011
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 137 (3) , 1124-1129
Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloids
- 1 October 2011
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 137 (3) , 1124-1129
Pharmacological actions of the South African medicinal and functional food plant Sceletium tortuosum and its principal alkaloids
- 15 July 2010
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 76 (11) , 1080-1086
High-Throughput Screening of Natural Products for Cancer Therapy
Natural products have been the biggest single source of anticancer drugs and there are continued efforts to explore the chemical diversity provided by nature in order to find new lead compounds. Bioassay test methods have developed into high throughput screening assays using both cell-based and molecular approaches. The various ways to detect effects on cell viability and cell proliferation are summarised and examples are given of developments using three-dimensional cultures and cancer stem cells. Cell-based reporter assays have also been created in order to look more directly for effects on specific physiological pathways. The molecular assays include those directed at microtubules and related proteins and at many different protein kinases.
- 15 July 2010
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 76 (11) , 1080-1086
High-Throughput Screening of Natural Products for Cancer Therapy
Natural products have been the biggest single source of anticancer drugs and there are continued efforts to explore the chemical diversity provided by nature in order to find new lead compounds. Bioassay test methods have developed into high throughput screening assays using both cell-based and molecular approaches. The various ways to detect effects on cell viability and cell proliferation are summarised and examples are given of developments using three-dimensional cultures and cancer stem cells. Cell-based reporter assays have also been created in order to look more directly for effects on specific physiological pathways. The molecular assays include those directed at microtubules and related proteins and at many different protein kinases.
- 30 April 2010
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 5 (6) , 559-568
Current strategies for drug discovery through natural products
Importance to the field: Natural products are the most consistently successful source of drug leads, both historically and currently. Despite this, the use of natural products in industrial drug discovery has fallen out of favour. Natural products are likely to continue to be sources of new commercially viable drug leads because the chemical novelty associated with natural products is higher than that of any other source: this is particularly important when searching for lead molecules against newly discovered targets for which there are no known small molecule leads.Areas to be covered: Current drug discovery strategies involving natural products are described in three sections: developments from traditionally used medicines, random testing of natural compounds on biological assays and use of virtual screening techniques with structures of natural products.What the reader will gain: The reader will gain an insight into the potential for natural products in current drug discovery paradigms, particularly i...
- 30 April 2010
- Published by Informa Healthcare in Expert Opinion on Drug Discovery
- Vol. 5 (6) , 559-568
Current strategies for drug discovery through natural products
Importance to the field: Natural products are the most consistently successful source of drug leads, both historically and currently. Despite this, the use of natural products in industrial drug discovery has fallen out of favour. Natural products are likely to continue to be sources of new commercially viable drug leads because the chemical novelty associated with natural products is higher than that of any other source: this is particularly important when searching for lead molecules against newly discovered targets for which there are no known small molecule leads.Areas to be covered: Current drug discovery strategies involving natural products are described in three sections: developments from traditionally used medicines, random testing of natural compounds on biological assays and use of virtual screening techniques with structures of natural products.What the reader will gain: The reader will gain an insight into the potential for natural products in current drug discovery paradigms, particularly i...
- 1 February 2010
- Vol. 13 (2) , 70-2
The role of natural products in drug discovery and development in the new millennium.
The role of Natural Products in Drug Discovery and development in the New Millennium meeting, held in London, included topics covering new developments in the field of natural products in drug discovery. This conference report highlights selected presentations on the value of natural products, natural-product screening opportunities and technological improvements to enhance the use of natural compounds in drug discovery and development.
- 1 February 2010
- Vol. 13 (2) , 70-2
The role of natural products in drug discovery and development in the new millennium.
The role of Natural Products in Drug Discovery and development in the New Millennium meeting, held in London, included topics covering new developments in the field of natural products in drug discovery. This conference report highlights selected presentations on the value of natural products, natural-product screening opportunities and technological improvements to enhance the use of natural compounds in drug discovery and development.
- 6 March 2009
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 7 (9) , 1829-1842
Diversity oriented syntheses of fused pyrimidines designed as potential antifolates
Diversity oriented syntheses of some furo[2,3-d]pyrimidines and pyrrolo[2,3-d]pyrimidines related to folate, guanine, and diaminopyrimidine-containing drugs have been developed for the preparation of potential anti-infective and anticancer compounds. Amide couplings and Suzuki couplings on the basic heterocyclic templates were used, in the latter case yields being especially high using aromatic trifluoroborates as the coupling partner. A new ring synthesis of 6-aryl-substituted deazaguanines bearing 2-alkylthio groups has been developed using Michael addition of substituted nitrostyrenes. Diversity at C-2 has been introduced by oxidation and substitution with a range of amino nucleophiles. The chemical reactivity of these pyrrolopyrimidines with respect to both electrophilic substitution in ring synthesis and nucleophilic substitution for diversity is discussed. Several compounds were found to inhibit pteridine reductases from the protozoan parasites Trypanosoma brucei and Leishmania major at the micromolar level and to inhibit the growth of Trypanosma brucei brucei in cell culture at higher concentrations. From these results, significant structural features required for inhibition of this important drug target enzyme have been identified.
- 6 March 2009
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 7 (9) , 1829-1842
Diversity oriented syntheses of fused pyrimidines designed as potential antifolates
Diversity oriented syntheses of some furo[2,3-d]pyrimidines and pyrrolo[2,3-d]pyrimidines related to folate, guanine, and diaminopyrimidine-containing drugs have been developed for the preparation of potential anti-infective and anticancer compounds. Amide couplings and Suzuki couplings on the basic heterocyclic templates were used, in the latter case yields being especially high using aromatic trifluoroborates as the coupling partner. A new ring synthesis of 6-aryl-substituted deazaguanines bearing 2-alkylthio groups has been developed using Michael addition of substituted nitrostyrenes. Diversity at C-2 has been introduced by oxidation and substitution with a range of amino nucleophiles. The chemical reactivity of these pyrrolopyrimidines with respect to both electrophilic substitution in ring synthesis and nucleophilic substitution for diversity is discussed. Several compounds were found to inhibit pteridine reductases from the protozoan parasites Trypanosoma brucei and Leishmania major at the micromolar level and to inhibit the growth of Trypanosma brucei brucei in cell culture at higher concentrations. From these results, significant structural features required for inhibition of this important drug target enzyme have been identified.
- Top Cited Papers
- 1 October 2008
- Published by Elsevier in Drug Discovery Today
- Vol. 13 (19-20) , 894-901
Natural products in drug discovery
- 1 October 2008
- Published by Elsevier in Drug Discovery Today
- Vol. 13 (19-20) , 894-901
Top Cited PapersNatural products in drug discovery
- 1 October 2007
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 11 (5) , 480-484
Natural products as a screening resource
- 1 October 2007
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 11 (5) , 480-484
Natural products as a screening resource
- 1 December 2004
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 11 (23) , 3065-3072
Dendrotoxins: Structure-Activity Relationships and Effects on Potassium Ion Channels
Dendrotoxins are small proteins isolated from mamba (Dendroaspis) snakes. The original dendrotoxin was found in venom of the Eastern green mamba, Dendroaspis angusticeps, and related proteins were subsequently found in other mamba venoms. The dendrotoxins contain 57-60 amino acid residues crosslinked by three disulphide bridges, and they are homologous to Kunitz-type serine protease inhibitors, such as aprotinin (BPTI). The dendrotoxins have little or no anti-protease activity, but they block particular subtypes of voltage-dependent potassium channels of the Kv1 subfamily in neurones. ?-Dendrotoxin from green mamba Dendroaspis angusticeps and toxin I from the black mamba Dendroaspis polylepis block cloned Kv1.1, Kv1.2 and Kv1.6 channels in the low nanomolar range; toxin K, also from the black mamba Dendroaspis polylepis, preferentially blocks Kv1.1 channels and is active at picomolar concentrations. Structural modifications and mutations to dendrotoxins have helped to define the molecular recognition properties of different types of K+ channels, although more work is needed to characterise the chemical features of the toxins that underlie their selectivity and potency at particular subtypes of channels. Dendrotoxins have been useful markers of subtypes of K+ channels in vivo, and dendrotoxins have become widely used as probes for studying the function of K+ channels in physiology and pathophysiology. With some pathological conditions being associated with voltage-gated K+ channels, analogues of dendrotoxins might have therapeutic potential.
- 1 December 2004
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 11 (23) , 3065-3072
Dendrotoxins: Structure-Activity Relationships and Effects on Potassium Ion Channels
Dendrotoxins are small proteins isolated from mamba (Dendroaspis) snakes. The original dendrotoxin was found in venom of the Eastern green mamba, Dendroaspis angusticeps, and related proteins were subsequently found in other mamba venoms. The dendrotoxins contain 57-60 amino acid residues crosslinked by three disulphide bridges, and they are homologous to Kunitz-type serine protease inhibitors, such as aprotinin (BPTI). The dendrotoxins have little or no anti-protease activity, but they block particular subtypes of voltage-dependent potassium channels of the Kv1 subfamily in neurones. ?-Dendrotoxin from green mamba Dendroaspis angusticeps and toxin I from the black mamba Dendroaspis polylepis block cloned Kv1.1, Kv1.2 and Kv1.6 channels in the low nanomolar range; toxin K, also from the black mamba Dendroaspis polylepis, preferentially blocks Kv1.1 channels and is active at picomolar concentrations. Structural modifications and mutations to dendrotoxins have helped to define the molecular recognition properties of different types of K+ channels, although more work is needed to characterise the chemical features of the toxins that underlie their selectivity and potency at particular subtypes of channels. Dendrotoxins have been useful markers of subtypes of K+ channels in vivo, and dendrotoxins have become widely used as probes for studying the function of K+ channels in physiology and pathophysiology. With some pathological conditions being associated with voltage-gated K+ channels, analogues of dendrotoxins might have therapeutic potential.